Speakers

Andrew Aherrera, M.D.
Partner
Panacea Venture
Christine Aylward
Founding & Managing Partner
Magnetic Ventures
Christiana Bardon, M.D.
Co-Managing Partner
MPM BioImpact
Joshua Berlin
Head of Corporate Alliances & Business Development
BioCentury Inc.
Karen Bernstein, Ph.D.
Co-Founder & Chairman
BioCentury Inc.
Nathalie Beslay
Co-Founder
NAAIA
Michelle Chen, Ph.D.
Board Member, BayHelix &
Chief Business Officer, Insilico Medicine
Arun Das, M.D.
Chief Business Officer
Cabaletta Bio
Shoibal Datta
Head of Digital Health Sciences
Takeda
Vishal Doshi
Chairman & CEO
AUM Biosciences
Simone Fishburn, Ph.D.
VP & Editor in Chief
BioCentury Inc.
David Flores
Co-Founder, President & CEO
BioCentury Inc.
Guangping GAO, Ph.D.
Director, Li Weibo Institute for Rare Diseases Research, and Director, Horae Gene Therapy Center and Viral Vector Core
UMass Chan Medical School
Jennifer Goldsack, MChem, MA, MBA, OLY
CEO
Digital Medicine Society
Colin Hill
CEO
Aitia
Zhi Hong, Ph.D.
Chairman & CEO
Brii Bioscience
Lisa Huang, Ph.D.
SVP
Curie.Bio
Hui-Yao HUANG, Ph.D.
Associate Professor & Academic Director, Clinical Trials Center, National Cancer Center
Chinese Academy of Medical Sciences
Alan Jiang, M.D., Ph.D.
Director & Chief Strategy Officer
XtalPi Inc.
Patricia Keegan, M.D.
Chief Medical Officer
Junshi Biosciences
Sophie Kornowski, Pharm.D.
CEO
Boston Pharmaceuticals
Olivier Leclerc
Senior Partner
McKinsey & Company
Arjen Lemmen
VP, Corporate Development & Strategy
argenx
Ji Li, Ph.D.
Principal
JL Biopharma Consulting
James Li, M.D.
CEO
JW Therapeutics
Zili Li, M.D. M.D., MPH
Fellow, Drug Information Association, and former VP & Head of Asia Pacific R&D
Johnson & Johnson
Yvonne Lu
Co-Lead, Global Biopharma Practice
Russell Reynolds Associates
Mathai Mammen, M.D., Ph.D.
Chairman & CEO
FogPharma
Lauren Martz
Executive Director of Biopharma Intelligence
BioCentury Inc.
Rachel Mears
Partner
Jeito Capital
Christopher Mortko
Head, Headquarters Search and Evaluation
Merck & Co.
Lonnie Moulder
Managing Member
Tellus BioVentures
David Ng, Ph.D.
Global VP Biometrics
Novotech
Kendalle Burlin O’Connell
CEO & President
MassBio
Wendy Pan, Ph.D.
Partner, Goodwin and
Chairwoman, BayHelix
Chong-Xian PAN, M.D., Ph.D.,
Associate Professor of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Immediate Past President
CAHON (Chinese American Hematologist and Oncologist Network)
Rajesh Parekh, Ph.D.
Senior Partner
McKinsey & Company
Greg Parekh, Ph.D.
Founder & Managing Partner
New Rhein Healthcare Investors
Raymond Pawlicki, Ph.D.
Executive Chairman
PrecisionLife
Robert Plenge, M.D., Ph.D.
EVP, Chief Research Officer
Bristol Myers Squibb
Andrew Plump, M.D., Ph.D.
President of R&D
Takeda Pharmaceutical Co. Ltd.
Jason Radford
SVP, Strategy and Corporate Development
BeiGene Ltd.
David Schechner
Partner
MTS Health Partners
Jian Shao
Head of Investment
Simcere Pharmaceutical
Josh Smiley
President & Chief Operating Officer
Zai Lab
Paula Soteropoulos
Venture Partner
5AM Ventures
Jackson Tai
Director
WuXi AppTec
Paul Peter Tak, M.D., Ph.D.
President and CEO
Candel Therapeutics
Yu Tang, M.D.
Executive Director, Clinical Trial Center
National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Benjamin Thorner
General Counsel & Chief Business Officer
Eikon Therapeutics
Karen Tkach Tuzman, Ph.D.
Director of Biopharma Intelligence and Head of Discovery and Preclinical Research
BioCentury Inc.
Chris Viehbacher
President & CEO
Biogen
Daniel von Bornstädt, M.D.
Associate Partner
McKinsey & Company
Jingsong Wang, M.D., Ph.D.
Chairman & CEO
Harbour BioMed
Andrea Wang-Gilliam, M.D., Ph.D.
Chief Medical Officer and Head of Global Affairs
Jacobio Pharmaceutical Group
Kathleen Williams, Ph.D.
Partner
Nutter McClennen & Fish LLP
Marietta Wu, M.D., Ph.D.
Managing Director
Quan Capital
Summer Xia
CEO
Hasten Pharma
Shanshan Xu, M.D., Ph.D.
Vice President, External Innovations
BioNTech US Inc.
James Xue, Ph.D.
Chairman & CEO
CANbridge Pharmaceuticals Inc.
Eric Yeung
VP & Head of Oncology and Rare Diseases Global Business Development
Takeda
Lin YU, Ph.D.
Managing Director
CBC Group
Guo-Liang Yu, Ph.D.
former Chairman, BayHelix and
Chairman & CEO, Apollomics Inc.
Derek Yuan, Ph.D.
Managing Director
LYFE Capital
Dan Zhang, M.D.
Co-Chairman
Hillgene
Jimmy Zhang, Ph.D.
Former Chairman, BayHelix, and Head of Business Development
Frontier Biotechnologies